HEALTH PROFESSIONAL · SOURCE READING

Treatment of Childhood AML

Source: Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

The general principles of therapy for children and adolescents with acute myeloid leukemia (AML) are discussed below. For information about the treatment of children with Down syndrome, see Childhood Myeloid Proliferations Associated With Down Syndrome Treatment. For information about the treatment of children with acute promyelocytic leukemia (APL), see Childhood Acute Promyelocytic Leukemia Treatment.

Source links and citations

Continue within this section

Induction Therapy →Central Nervous System (CNS) Prophylaxis for AML →Postremission Therapy for AML →Treatment Options Under Clinical Evaluation →

Preserved source evidence · Not medical advice